|
Specifications_on_immunosuppressive_medication_use
|
Specifications_on_immunosuppressive_medication_use |
|
|
pre-existing_condition
|
pre-existing_condition |
|
|
ammonia
|
ammonia |
|
|
thrombocytopenia
|
thrombocytopenia |
|
|
Course_of_infiltrates_in_imaging
|
Course_of_infiltrates_in_imaging |
|
|
Occult_Blood
|
Occult_Blood |
|
|
Information_from_relatives
|
Information_from_relatives |
|
|
study_design
|
study_design |
|
|
Is_the_patient_participating_in_a_drug_study?
|
Is_the_patient_participating_in_a_drug_study? |
|
|
Decreasing
|
Decreasing |
|
|
antimicrobial_susceptibility_testing
|
antimicrobial_susceptibility_testing |
[This view contains the results of testing the susceptibility of patient-borne microbes t treatment by antibiotics.] |
|
Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic method
|
3176-5 |
|
|
pH of Serum or Plasma
|
2753-2 |
|
|
How_many_days_before_admission_has_the_patient_felt_breathless?
|
How_many_days_before_admission_has_the_patient_felt_breathless? |
|
|
Relavant_ischemia
|
Relavant_ischemia |
|
|
Assessments_of_the_cardiac_MRI
|
Assessments_of_the_cardiac_MRI |
|
|
glycopeptide_antibiotic
|
glycopeptide_antibiotic |
|
|
antibacterial_agent_therapy
|
antibacterial_agent_therapy |
|
|
ineffective
|
ineffective |
|
|
Change_Reason
|
Change_Reason |
|
